MK-0431A XR
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MK-0431A XR, covering 2015-05-22 to 2020-10-05. Get the full timeline:
Most recent: Clinical Trial Update: A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289) [Phase 3]